Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Finance

Calithera metabolizes

Calithera's second act as cancer metabolism play attracts $35M

November 4, 2013 8:00 AM UTC

Calithera Biosciences Inc. has reinvented itself as a cancer metabolism play since it last raised money. A strong belief in the company's management lured back at least one existing investor in last week's $35 million series D round led by new investor Adage Capital Partners.

New investors Longwood Fund and two undisclosed institutional investors also participated, along with existing investors Morgenthaler Ventures, Advanced Technology Ventures and Delphi Ventures...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article